News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
200,990 Results
Type
Article (8402)
Company Profile (16)
Press Release (192569)
Multimedia
Podcasts (12)
Webinars (8)
Section
Business (76308)
Career Advice (456)
Deals (11117)
Drug Delivery (23)
Drug Development (22164)
Employer Resources (53)
FDA (4224)
Job Trends (4081)
News (113066)
Policy (8198)
Tag
Academia (695)
Accelerated approval (7)
Adcomms (12)
Allergies (38)
Alliances (13135)
ALS (37)
Alzheimer's disease (509)
Antibody-drug conjugate (ADC) (97)
Approvals (4369)
Artificial intelligence (142)
Autoimmune disease (27)
Automation (6)
Bankruptcy (74)
Best Places to Work (3443)
BIOSECURE Act (3)
Biosimilars (46)
Biotechnology (7)
Bladder cancer (32)
Brain cancer (9)
Breast cancer (138)
Cancer (1359)
Cardiovascular disease (87)
Career advice (387)
Career pathing (10)
CAR-T (51)
CDC (4)
Celiac Disease (1)
Cell therapy (161)
Cervical cancer (13)
Clinical research (19549)
Collaboration (439)
Compensation (51)
Complete response letters (6)
COVID-19 (538)
CRISPR (20)
C-suite (250)
Cystic fibrosis (35)
Data (1822)
Decentralized trials (1)
Denatured (6)
Depression (8)
Diabetes (127)
Diagnostics (2079)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (60)
Drug pricing (25)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (44313)
Editorial (6)
Employer branding (8)
Employer resources (49)
Events (28449)
Executive appointments (282)
FDA (5073)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (306)
Gene editing (38)
Generative AI (15)
Gene therapy (121)
GLP-1 (174)
Government (1010)
Grass and pollen (2)
Guidances (222)
Healthcare (5054)
HIV (21)
Huntington's disease (6)
IgA nephropathy (21)
Immunology and inflammation (38)
Immuno-oncology (17)
Indications (38)
Infectious disease (599)
Inflammatory bowel disease (51)
Influenza (26)
Intellectual property (71)
Interviews (67)
IPO (5677)
IRA (3)
Job creations (807)
Job search strategy (351)
JPM (8)
Kidney cancer (10)
Labor market (10)
Layoffs (82)
Leadership (8)
Legal (1503)
Liver cancer (23)
Longevity (2)
Lung cancer (234)
Lymphoma (133)
Machine learning (13)
Management (20)
Manufacturing (188)
MASH (27)
Medical device (4263)
Medtech (4281)
Mergers & acquisitions (5654)
Metabolic disorders (259)
Multiple sclerosis (44)
Neurodegenerative disease (84)
Neuropsychiatric disorders (6)
Neuroscience (798)
NextGen: Class of 2026 (1627)
Non-profit (1211)
Now hiring (5)
Obesity (112)
Opinion (55)
Ovarian cancer (41)
Pain (32)
Pancreatic cancer (55)
Parkinson's disease (105)
Partnered (7)
Patents (101)
Patient recruitment (105)
Peanut (22)
People (19337)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase 1 (5228)
Phase 2 (8267)
Phase 3 (7386)
Pipeline (1729)
Policy (35)
Postmarket research (798)
Preclinical (2146)
Press Release (12)
Prostate cancer (77)
Psychedelics (3)
Radiopharmaceuticals (91)
Rare diseases (171)
Real estate (1505)
Recruiting (21)
Regulatory (6762)
Reports (9)
Research institute (667)
Resumes & cover letters (64)
Rett syndrome (6)
RSV (17)
Schizophrenia (36)
Series A (59)
Series B (38)
Service/supplier (1)
Sickle cell disease (19)
Spinal muscular atrophy (28)
Sponsored (13)
Startups (849)
Stomach cancer (5)
Supply chain (20)
Tariffs (16)
The Weekly (6)
Vaccines (222)
Venture capital (24)
Weight loss (48)
Women's health (17)
Worklife (5)
Date
Last 7 days (150)
Last 30 days (541)
Last 365 days (8120)
2026 (692)
2025 (8163)
2024 (9500)
2023 (11475)
2022 (15215)
2021 (16557)
2020 (15867)
2019 (13680)
2018 (10488)
2017 (10652)
2016 (9613)
2015 (11892)
2014 (8416)
2013 (6518)
2012 (7145)
2011 (7637)
2010 (6702)
Location
Africa (259)
Alabama (10)
Arizona (50)
Arkansas (1)
Asia (15038)
Australia (2701)
California (2622)
Canada (910)
China (444)
Colorado (141)
Connecticut (84)
Delaware (78)
Europe (32626)
Florida (457)
Georgia (96)
Hawaii (2)
Idaho (24)
Illinois (225)
India (21)
Indiana (166)
Iowa (3)
Japan (171)
Kansas (24)
Kentucky (8)
Louisiana (16)
Maine (51)
Maryland (329)
Massachusetts (1808)
Michigan (104)
Minnesota (177)
Missouri (36)
Montana (12)
Nebraska (6)
Nevada (41)
New Hampshire (28)
New Jersey (983)
New Mexico (5)
New York (712)
North Carolina (406)
North Dakota (2)
Northern California (1222)
Ohio (73)
Oklahoma (5)
Oregon (6)
Pennsylvania (569)
Puerto Rico (6)
Rhode Island (7)
South America (437)
South Carolina (20)
Southern California (1142)
Tennessee (26)
Texas (357)
United States (9863)
Utah (91)
Virginia (34)
Washington D.C. (14)
Washington State (217)
West Virginia (1)
Wisconsin (33)
Wyoming (2)
200,990 Results for "orbis international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Orbis International and NIDEK Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam
Orbis International announces an important in-kind and financial donation from NIDEK to support Orbis’s artificial intelligence -based screening services in Vietnam.
January 16, 2024
·
4 min read
Business
Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
Global eye care nonprofit, Orbis International, is kicking off a surgical training program in Zambia on board the Orbis Flying Eye Hospital - the world’s only fully accredited ophthalmic teaching hospital on board a plane.
September 25, 2023
·
7 min read
Press Releases
Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair
March 5, 2025
·
5 min read
Press Releases
OS Therapies Receives Positive Feedback from UK MHRA Scientific Advice Meeting and Submits Innovative Licensing and Access Pathway (ILAP) Request for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
MHRA seeks to harmonize UK & US regulatory review via Project Orbis EMA Rapporteur Scientific Advice Meeting scheduled for October 2025
August 7, 2025
·
5 min read
Policy
Agitated Solutions Receives Health Canada License for Orbis Microbubble Generator to Streamline Cardiac Bubble Studies
Agitated Solutions, Incorporated announced that it has been issued a Medical Device Establishment License from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.
April 18, 2024
·
3 min read
Press Releases
Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles
January 6, 2025
·
3 min read
Business
Novo Holdings, Forbion Lead Financing for Orbis Medicine’s $28M Seed Round
Denmark-based startup Orbis Medicines has launched with €26 million in seed funding in its drive to search for macrocycle drugs, with a focus on high-value oral alternatives to blockbuster biologics.
February 29, 2024
·
2 min read
·
Tyler Patchen
Job Trends
Talent Acquisition Leaders Reframe Recruiting, Focus On Internal Mobility
Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies
,
including automation
,
to develop internal talent marketplaces and systems that support upskilling and reskilling their workforce.
BioSpace
spoke to leaders at Pfizer and Bayer about their evolving approach to resourcing.
September 24, 2025
·
3 min read
·
Chantal Dresner
Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’
Orbis Medicines, a leader in oral macrocycle drug discovery, announces its launch with a €26 million financing led by global life sciences investor Novo Holdings and European life sciences venture firm Forbion.
February 29, 2024
·
6 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
1 of 20,099
Next
